Cargando…
CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
The discovery and development of the CRISPR/Cas system is a milestone in precise medicine. CRISPR/Cas nucleases, base-editing (BE) and prime-editing (PE) are three genome editing technologies derived from CRISPR/Cas. In recent years, CRISPR-based genome editing technologies have created immense ther...
Autores principales: | Li, Ruiting, Wang, Qin, She, Kaiqin, Lu, Fang, Yang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560888/ https://www.ncbi.nlm.nih.gov/pubmed/36239875 http://dx.doi.org/10.1186/s43556-022-00095-y |
Ejemplares similares
-
CRISPR-Cas systems: ushering in the new genome editing era
por: Perez Rojo, Fernando, et al.
Publicado: (2018) -
Biosafety materials: Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system
por: Zhang, Yuquan, et al.
Publicado: (2022) -
Brookhaven ushers in a new bright era
Publicado: (2015) -
Ushering in the era of penile transplantation
por: Rasper, Alison M., et al.
Publicado: (2017) -
Ushering in a new era of RNA-based therapies
por: DeLong, Robert
Publicado: (2021)